- Home
- MIN vs AQST Comparison
MIN vs AQST Comparison
Compare MIN & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIN
- AQST
- Stock Information
- Founded
- MIN 1988
- AQST 2004
- Country
- MIN United States
- AQST United States
- Employees
- MIN N/A
- AQST N/A
- Industry
- MIN Trusts Except Educational Religious and Charitable
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- MIN Finance
- AQST Health Care
- Exchange
- MIN Nasdaq
- AQST Nasdaq
- Market Cap
- MIN 306.1M
- AQST 274.4M
- IPO Year
- MIN N/A
- AQST 2018
- Fundamental
- Price
- MIN $2.72
- AQST $2.86
- Analyst Decision
- MIN
- AQST Strong Buy
- Analyst Count
- MIN 0
- AQST 7
- Target Price
- MIN N/A
- AQST $10.57
- AVG Volume (30 Days)
- MIN 331.0K
- AQST 1.3M
- Earning Date
- MIN 01-01-0001
- AQST 03-05-2025
- Dividend Yield
- MIN 7.31%
- AQST N/A
- EPS Growth
- MIN N/A
- AQST N/A
- EPS
- MIN 0.08
- AQST N/A
- Revenue
- MIN N/A
- AQST $57,561,000.00
- Revenue This Year
- MIN N/A
- AQST N/A
- Revenue Next Year
- MIN N/A
- AQST $39.51
- P/E Ratio
- MIN $33.38
- AQST N/A
- Revenue Growth
- MIN N/A
- AQST 13.79
- 52 Week Low
- MIN $2.52
- AQST $2.24
- 52 Week High
- MIN $2.88
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- MIN 56.97
- AQST 45.84
- Support Level
- MIN $2.66
- AQST $3.05
- Resistance Level
- MIN $2.73
- AQST $3.24
- Average True Range (ATR)
- MIN 0.03
- AQST 0.19
- MACD
- MIN 0.00
- AQST 0.01
- Stochastic Oscillator
- MIN 83.33
- AQST 22.06
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.